| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.2M | -99.9% |
| R&D Expense | $461.6M | +5.2% |
| SG&A Expense | $102.5M | -0.3% |
| Operating Income | -$673.2M | -280.2% |
| Pre-tax Income | -$650.5M | -271.4% |
| Income Tax | -$325K | -117.4% |
| Net Income | -$650.2M | -272.2% |
| EPS (Basic) | -$8.36 | -268.2% |
| EPS (Diluted) | -$8.36 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $211.9M | -77.0% |
| Short-term Investments | $1.60B | +10.1% |
| Accounts Receivable | $0 | -100.0% |
| Current Assets | $1.85B | -23.3% |
| Total Assets | $2.24B | -18.5% |
| Current Liabilities | $121.1M | +1.0% |
| Total Liabilities | $367.6M | +4.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$495.7M | -192.0% |
| Capital Expenditures | $37.2M | -54.5% |
| Investing Cash Flow | -$258.7M | +75.0% |
| Financing Cash Flow | $38.6M | -84.6% |
| Free Cash Flow | -$532.9M | -216.5% |
| -277.9% |
| Stockholders' Equity |
| $1.88B |
| -21.8% |